• Effective July 2, 2014, patient groups will now have 35 business days to prepare and submit their patient input submissions to CDR
• This is possible due to the mandatory pre-submission advance notice policy which will be going into effect the same day. As per the policy, manufacturers must provide a minimum of 20 business days advanced notice that they will be filing a submission to CDR
• CADTH will be sending out calls for patient submissions for all currently queued submissions in the coming weeks via E-Alerts and Twitter
• It is important to note that while CDR submissions are queued, posting of calls for patient input does not indicate that the reviews have been initiated. CADTH will notify manufacturers by email on the day that the CDR review of a particular drug is initiated

For more information on the new patient input timeline and the mandatory advance notice policy, please see CDR Update – Issue 105.